Business Context and Reporting Period
This Form 8-K is a current report filed by Artelo Biosciences, Inc. (Nasdaq: ARTL) on January 2, 2026, regarding events occurring on December 31, 2025. The filing addresses the status of the Company's 2025 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance proceedings and does not contain financial performance data.
Material Changes and Corporate Events
- Adjournment of Annual Meeting: The 2025 Annual Meeting convened on December 31, 2025, was adjourned without conducting business due to insufficient votes to constitute a quorum.
- Rescheduled Meeting: The meeting will reconvene on Friday, January 30, 2026, at 8:00 a.m. Pacific Time.
- Meeting Format: The reconvened meeting will be held virtually via live audio webcast at https://www.proxyvote.com/.
- Additional Proposal: A new proposal to ratify the appointment of Malone Bailey LLP as the independent auditor for the fiscal year ending December 31, 2026, is anticipated to be added to the agenda.
- Record Date: The record date for voting remains December 10, 2025. Previously submitted proxies remain valid unless revoked.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements cautioning that actual results may differ materially from expectations due to known and unknown risks. No specific financial guidance, operational outlook, or management commentary regarding business performance is provided in this document. The primary contingency noted is the requirement to successfully achieve a quorum at the rescheduled meeting to vote on the proposed matters.
Investor Verification Checklist
- Verify the reconvened Annual Meeting date and time (January 30, 2026, 8:00 a.m. PT).
- Confirm the availability of supplemental proxy materials regarding the auditor ratification proposal.
- Check the status of previously submitted proxies to ensure they are still valid for the rescheduled meeting.
- Review the definitive proxy statement filed on December 11, 2025, for details on the original proposals.